These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 21898494)
1. Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers? Mato JM; Lu SC Hepatology; 2011 Oct; 54(4):1115-7. PubMed ID: 21898494 [No Abstract] [Full Text] [Related]
2. [Nonalcoholic steatohepatitis: epidemiology, diagnosis and treatment]. Tilg H Dtsch Med Wochenschr; 2001 Apr; 126(16):467-71. PubMed ID: 11360453 [No Abstract] [Full Text] [Related]
3. Nonalcoholic fatty liver disease: a challenge for pediatricians. Widhalm K; Ghods E Int J Obes (Lond); 2010 Oct; 34(10):1451-67. PubMed ID: 20838401 [TBL] [Abstract][Full Text] [Related]
4. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience. Munteanu M; Ratziu V; Morra R; Messous D; Imbert-Bismut F; Poynard T J Gastrointestin Liver Dis; 2008 Jun; 17(2):187-91. PubMed ID: 18568141 [No Abstract] [Full Text] [Related]
5. Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins. Bookman ID; Pham J; Guindi M; Heathcote EJ Liver Int; 2006 Jun; 26(5):566-71. PubMed ID: 16762001 [TBL] [Abstract][Full Text] [Related]
6. Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents. Schwimmer JB Semin Liver Dis; 2007 Aug; 27(3):312-8. PubMed ID: 17682977 [TBL] [Abstract][Full Text] [Related]
16. Clinical update on non-alcoholic fatty liver disease and steatohepatitis. Bugianesi E; Bellentani S; Bedogni G; Tiribelli C; Ann Hepatol; 2008; 7(2):157-60. PubMed ID: 18626435 [No Abstract] [Full Text] [Related]
17. [Clinical features of NASH]. Shimada M; Takase S Nihon Rinsho; 2006 Jun; 64(6):1114-8. PubMed ID: 16768118 [TBL] [Abstract][Full Text] [Related]
18. [Significance of various diagnostic parameters in chronic liver diseases]. Heinicke HJ Z Gesamte Inn Med; 1973 Feb; 28(4):93-101. PubMed ID: 4540734 [No Abstract] [Full Text] [Related]
19. Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. Manousou P; Kalambokis G; Grillo F; Watkins J; Xirouchakis E; Pleguezuelo M; Leandro G; Arvaniti V; Germani G; Patch D; Calvaruso V; Mikhailidis DP; Dhillon AP; Burroughs AK Liver Int; 2011 May; 31(5):730-9. PubMed ID: 21457446 [TBL] [Abstract][Full Text] [Related]